T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NXP Semiconductors
NXPI
|
+$1.36B |
| 2 |
Philip Morris
PM
|
+$1.3B |
| 3 |
Amazon
AMZN
|
+$1.21B |
| 4 |
Stryker
SYK
|
+$1.12B |
| 5 |
AET
Aetna Inc
AET
|
+$1.08B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bausch Health
BHC
|
+$1.46B |
| 2 |
Gilead Sciences
GILD
|
+$1.1B |
| 3 |
Walt Disney
DIS
|
+$866M |
| 4 |
Akamai
AKAM
|
+$703M |
| 5 |
Chipotle Mexican Grill
CMG
|
+$647M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 21.13% |
| 2 | Consumer Discretionary | 15.13% |
| 3 | Financials | 13.68% |
| 4 | Technology | 12.92% |
| 5 | Industrials | 10.21% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
AXE
1276
DELISTED
Anixter International Inc
AXE
| $9.49M | ﹤0.01% |
182,070
-3,600
| -2% | -$169K |
|
|
GCP
1277
DELISTED
GCP Applied Technologies Inc.
GCP
| $9.46M | ﹤0.01% |
+474,497
| New | +$8.62M |
|
1278
Dick's Sporting Goods
DKS
$18.1B
| $9.41M | ﹤0.01% |
201,393
+3,254
| +2% | +$132K |
|
|
BID
1279
DELISTED
Sotheby's
BID
| $9.39M | ﹤0.01% |
351,196
-22,600
| -6% | -$543K |
|
1280
Agios Pharmaceuticals
AGIO
$1.97B
| $9.39M | ﹤0.01% |
231,179
+10,560
| +5% | +$451K |
|
|
MNTA
1281
DELISTED
Momenta Pharmaceuticals, Inc.
MNTA
| $9.32M | ﹤0.01% |
1,008,564
-258,055
| -20% | -$2.78M |
|
|
WLH
1282
DELISTED
WILLIAM LYON HOMES
WLH
| $9.3M | ﹤0.01% |
642,015
+8,300
| +1% | +$98.3K |
|
|
BPMC
1283
DELISTED
Blueprint Medicines
BPMC
| $9.24M | ﹤0.01% |
511,808
-22,040
| -4% | -$382K |
|
|
AJRD
1284
DELISTED
Aerojet Rocketdyne Holdings
AJRD
| $9.19M | ﹤0.01% |
561,110
+20,900
| +4% | +$327K |
|
|
PPLI
1285
People Inc
PPLI
$3.01B
| $9.03M | ﹤0.01% |
1,073,305
+95,351
| +10% | +$821K |
|
1286
Corvus Pharmaceuticals
CRVS
$1.27B
| $8.95M | ﹤0.01% |
+634,988
| New | +$9.11M |
|
1287
CorVel
CRVL
$3.32B
| $8.92M | ﹤0.01% |
678,858
-10,200
| -1% | -$143K |
|
|
SFLY
1288
DELISTED
Shutterfly, Inc.
SFLY
| $8.86M | ﹤0.01% |
191,000
-20,100
| -10% | -$857K |
|
1289
A.O. Smith
AOS
$8.48B
| $8.84M | ﹤0.01% |
231,672
-510,400
| -69% | -$17.8M |
|
1290
Take-Two Interactive
TTWO
$46.5B
| $8.8M | ﹤0.01% |
233,565
+208,500
| +832% | +$7.22M |
|
1291
PRA Group
PRAA
$775M
| $8.79M | ﹤0.01% |
298,970
-27,000
| -8% | -$777K |
|
|
BFX
1292
DELISTED
BowFlex Inc.
BFX
| $8.72M | ﹤0.01% |
+451,490
| New | +$8.48M |
|
1293
Charter Communications
CHTR
$18.6B
| $8.68M | ﹤0.01% |
42,893
+5,217
| +14% | +$936K |
|
1294
IPG Photonics
IPGP
$3.59B
| $8.63M | ﹤0.01% |
89,871
-246,389
| -73% | -$20.9M |
|
|
ECHO
1295
EchoStar
ECHO
$26.5B
| $8.59M | ﹤0.01% |
239,411
-11,723
| -5% | -$373K |
|
|
PBCT
1296
DELISTED
People's United Financial Inc
PBCT
| $8.59M | ﹤0.01% |
539,227
-7,200
| -1% | -$108K |
|
1297
Navient
NAVI
$848M
| $8.55M | ﹤0.01% |
714,373
-10,050
| -1% | -$105K |
|
|
ANSS
1298
DELISTED
Ansys
ANSS
| $8.54M | ﹤0.01% |
95,472
+10,885
| +13% | +$939K |
|
1299
Digital Realty Trust
DLR
$73.9B
| $8.48M | ﹤0.01% |
95,786
-3,763,016
| -98% | -$305M |
|
|
HZNP
1300
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
| $8.34M | ﹤0.01% |
503,282
+10,600
| +2% | +$185K |
|
Similar funds
T. Rowe Price Associates's Q1 2016 Portfolio in Review
As of Q1 2016, T. Rowe Price Associates held 2,594 positions worth $468B, down 1.5% from $475B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
T. Rowe Price Associates's Q1 2016 filing shows 78 new, 1,210 increased, 770 reduced and 91 closed positions. Its largest new stake was BRF SA: 5,750,603 shares worth $81.8M. The largest sale was Bausch Health, an estimated $1.46B.
By sector, the portfolio is most concentrated in Healthcare at 21% of assets, down from 23% a quarter earlier, followed by Consumer Discretionary and Financials.
- T. Rowe Price Associates's largest Q1 2016 buy was BRF SA: 5,750,603 shares worth $81.8M.
- T. Rowe Price Associates added most to NXP Semiconductors in Q1 2016, an estimated $1.36B increase.
- T. Rowe Price Associates's biggest Q1 2016 reduction was Bausch Health, cutting an estimated $1.46B.
- T. Rowe Price Associates fully exited CHUBB CORPORATION in Q1 2016, selling an estimated $496M.
- T. Rowe Price Associates's ten largest holdings make up 16% of its $468B portfolio in Q1 2016.
- T. Rowe Price Associates opened 78 new positions and closed 91 in Q1 2016.
- T. Rowe Price Associates's portfolio value fell 1.5% quarter-over-quarter to $468B.
Based on T. Rowe Price Associates's 13F filing for Q1 2016, filed 16 May 2016.